FDA.reportPublic FDA data

Tpoxx 200 MG Oral Capsule

RxCUI
2055115
RxNorm name
Tpoxx 200 MG Oral Capsule
Display name
Tpoxx 200 MG Oral Capsule
Full name
Tpoxx 200 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TPOXXTECOVIRIMAT MONOHYDRATESIGA Technologies, Inc.fce826ab-4d6a-4139-a2ee-a304a913a2532025-12-31Warnings, Adverse reactionsExact identifier
rxcui: 2055115

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fce826ab-4d6a-4139-a2ee-a304a913a253TPOXX 200 MG Oral Capsule [PSN] · tecovirimat 200 MG Oral Capsule [Tpoxx] [SBD] · Tpoxx 200 MG Oral Capsule [SY]317These highlights do not include all the information needed to use TPOXX ® safely and effectively. See full prescribing information for TPOXX. TPOXX (tecovirimat) capsules, for oral use TPOXX (tecovirimat) injection for intravenous use Initial U.S. Approval: 201820251231